Related Experiment Videos
Polyglutamine repeat length-dependent proteolysis of huntingtin
Banghua Sun1, Wei Fan, Aldona Balciunas
1Amgen Inc., Thousand Oaks, California 91320, USA.
Neurobiology of Disease
|December 4, 2002
Summary
Huntington's disease (HD) pathology may involve amino-terminal huntingtin fragments. Researchers identified a specific cleavage site in huntingtin that is more active in pathological forms of the disease.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Huntington's disease (HD) is linked to expanded polyglutamine (polyQ) repeats in the huntingtin (HTT) protein.
- Intranuclear inclusions of truncated N-terminal HTT fragments are observed in HD patients and models.
- These N-terminal fragments are considered more toxic than full-length HTT.
Purpose of the Study:
- To identify a specific cleavage site within huntingtin responsible for generating pathogenic fragments.
- To investigate the relationship between polyQ repeat length and the cleavage efficiency of huntingtin.
Main Methods:
- Cell-based assays using cultured cells expressing huntingtin constructs.
- Analysis of proteolytic cleavage within a defined region of huntingtin (amino acids 63-111).
- Comparison of cleavage efficiency between huntingtin with pathological and non-pathological polyQ repeat lengths.
Main Results:
- A specific region (amino acids 63-111) within huntingtin was identified as a cleavage site.
- Cleavage within this region generates N-terminal fragments similar in size to those found in HD patients.
- Proteolytic cleavage is more efficient in huntingtin with pathological polyQ repeat lengths compared to non-pathological ones.
Conclusions:
- The identified cleavage site (amino acids 63-111) is crucial for generating toxic N-terminal huntingtin fragments in HD.
- PolyQ repeat length directly influences the proteolytic processing of huntingtin, suggesting a mechanism for HD pathogenesis.
- This cleavage event represents a potential therapeutic target for reducing toxic fragment accumulation in Huntington's disease.